Military Veterans Win NHS Cannabis Prescription After Campaign

A group of 14 military veterans with diagnosed post-traumatic stress disorder have become among the first patients in England to receive NHS-funded cannabis-based medicinal product prescriptions for a mental health indication, following a two-year advocacy campaign that attracted significant parliamentary and media attention.

Background to the Campaign

The veterans, all of whom served with UK armed forces in Afghanistan or Iraq, had been self-medicating with cannabis for PTSD symptoms for several years before seeking legal routes to treatment. A veterans support charity connected the group with a specialist psychiatric team and a pro-bono legal adviser who worked with NHS commissioners to make the case for funded prescribing.

Clinical Pathway Established

Following the campaign success, the relevant NHS Integrated Care Board has agreed a formal prescribing pathway for veterans with treatment-resistant PTSD. The pathway requires:

• Confirmed PTSD diagnosis from an NHS or accredited specialist psychiatrist
• Evidence of failure to respond to at least two first-line PTSD treatments including trauma-focused CBT
• Assessment by a consultant psychiatrist with specific CBMP prescribing competency
• Regular outcome monitoring using standardised PTSD assessment tools

Wider Impact

The campaign outcome is expected to be cited in forthcoming NICE guidance reviews and in ongoing parliamentary discussions about NHS CBMP access. Veterans organisations across the UK have welcomed the decision as a precedent with potential significance beyond the immediate group.

"These men and women served this country and came home carrying wounds that cannot be seen. They deserve every available treatment option, including this one."